Insider Trading & Ownership - Posner Christopher

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Posner Christopher
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2024-11-04
Sale
2024-11-06
4:51 pm
Cara Therapeutics Inc.CARAPosner Christopher
PRESIDENT AND CEO
3,668$0.29$1,064168,768
(Direct)
View
2024-08-01
Sale
2024-08-02
4:05 pm
Cara Therapeutics Inc.CARAPosner Christopher
PRESIDENT AND CEO
4,149$0.35$1,452172,436
(Direct)
View
2024-05-02
Sale
2024-05-06
4:15 pm
Cara Therapeutics Inc.CARAPosner Christopher
PRESIDENT AND CEO
3,936$0.75$2,952176,585
(Direct)
View
2024-02-29
Sale
2024-03-04
4:19 pm
Cara Therapeutics Inc.CARAPosner Christopher
PRESIDENT AND CEO
5,834$0.89$5,192180,521
(Direct)
View
2024-02-08
Sale
2024-02-12
5:10 pm
Cara Therapeutics Inc.CARAPosner Christopher
PRESIDENT AND CEO
35,575$0.53$18,855186,355
(Direct)
View
2024-02-01
Sale
2024-02-05
4:26 pm
Cara Therapeutics Inc.CARAPosner Christopher
PRESIDENT AND CEO
4,981$0.55$2,740221,930
(Direct)
View
2023-11-02
Sale
2023-11-03
4:37 pm
Cara Therapeutics Inc.CARAPosner Christopher
President and CEO
3,796$1.22$4,631164,411
(Direct)
View
2023-08-03
Sale
2023-08-04
5:21 pm
Cara Therapeutics Inc.CARAPosner Christopher
President and CEO
4,307$3.07$13,222168,207
(Direct)
View
2023-05-05
Sale
2023-05-09
4:22 pm
Cara Therapeutics Inc.CARAPosner Christopher
President and CEO
3,869$4.4$17,024172,514
(Direct)
View
2023-03-03
Sale
2023-03-07
4:47 pm
Cara Therapeutics Inc.CARAPosner Christopher
President and CEO
5,987$9.71$58,134176,383
(Direct)
View
2023-02-02
Sale
2023-02-03
6:38 pm
Cara Therapeutics Inc.CARAPosner Christopher
President and CEO
4,191$11.8$49,454182,370
(Direct)
View
2022-11-16
Sale
2022-11-18
5:23 pm
Cara Therapeutics Inc.CARAPosner Christopher
President and CEO
14,470$11.13$161,051186,561
(Direct)
View
2022-04-04
Sale
2022-04-05
5:48 pm
Cara Therapeutics Inc.CARAPosner Christopher
President and CEO
2,006$12.67$25,416201,031
(Direct)
View
2021-06-07
Sale
2021-06-07
7:33 pm
Cara Therapeutics Inc.CARAPosner Christopher
Director
2,304$13.04$30,04426,896
(Direct)
View
2020-11-19
Sale
2020-11-23
8:28 pm
Cara Therapeutics Inc.CARAPosner Christopher
Director
2,000$15.82$31,63811,200
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2024-02-01
Option Award
2024-02-05
4:26 pm
N/A
N/A
Cara Therapeutics Inc.CARAPosner Christopher
PRESIDENT AND CEO
62,500$0221,930
(Direct)
View
2023-03-01
Option Award
2023-03-03
4:35 pm
N/A
2033-03-01
Cara Therapeutics Inc.CARAPosner Christopher
President and CEO
250,000$0250,000
(Direct)
View

Ownership
2022-11-30
4:40 pm
N/A
2032-11-27
KEMPHARM INCKMPHPosner Christopher
Director
0$022,500
(Direct)
View
2022-02-25
Option Award
2022-03-01
4:17 pm
N/A
2032-02-25
Cara Therapeutics Inc.CARAPosner Christopher
President and CEO
160,000$0324,037
(Direct)
View
2021-10-29
Option Award
2021-11-03
08:15 am
N/A
2031-10-29
Cara Therapeutics Inc.CARAPosner Christopher
Senior Advisor
713,941$0730,037
(Direct)
View
2021-06-03
Option Award
2021-06-07
7:33 pm
N/A
2031-06-03
Cara Therapeutics Inc.CARAPosner Christopher
Director
18,000$026,896
(Direct)
View
2020-06-04
Option Award
2020-06-08
5:46 pm
N/A
2030-06-04
Cara Therapeutics Inc.CARAPosner Christopher
Director
18,000$024,000
(Direct)
View